BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10583335)

  • 1. Double esterase staining of the bone marrow contributes to lineage identification in a case of minimally differentiated acute myeloid leukaemia (AML M0).
    Elghetany MT
    Clin Lab Haematol; 1999 Aug; 21(4):293-5. PubMed ID: 10583335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody anti-MPO is useful in recognizing minimally differentiated acute myeloid leukaemia.
    Praxedes MK; De Oliveira LZ; Pereira Wda V; Quintana IZ; Tabak DG; De Oliveira MS
    Leuk Lymphoma; 1994 Jan; 12(3-4):233-9. PubMed ID: 8167554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO).
    Bennett JM; Catovsky D; Daniel MT; Flandrin G; Galton DA; Gralnick HR; Sultan C
    Br J Haematol; 1991 Jul; 78(3):325-9. PubMed ID: 1651754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M; Kusenda J; Babusikova O
    Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electron microscopic and cytochemical studies of peroxidase-negative acute nonlymphoblastic leukemia.
    Eguchi M; Mikami T; Kurosawa H; Sugita K; Furukawa T; Tsunoda S; Miura Y
    Med Electron Microsc; 2001 Mar; 34(1):61-70. PubMed ID: 11479774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimally differentiated acute myeloid leukaemia (AML-M0): cytochemical, immunophenotypic and cytogenetic analysis of 19 cases.
    Venditti A; Del Poeta G; Stasi R; Masi M; Bruno A; Buccisano F; Cox C; Coppetelli U; Aronica G; Simone MD
    Br J Haematol; 1994 Dec; 88(4):784-93. PubMed ID: 7819103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The evaluation of cytochemical criteria in the diagnosis of acute myeloid leukemia].
    Lohins'kyĭ VO; Vyhovs'ka IaI; Tsymbaliuk IP; Masliak ZV; Mazurok AA
    Lik Sprava; 1998; (2):54-8. PubMed ID: 9670656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimally differentiated acute myeloid leukaemia revealed by specific cutaneous lesions.
    Benucci R; Annessi G; Signoretti S; Simoni R
    Br J Dermatol; 1996 Jul; 135(1):119-23. PubMed ID: 8776374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single incubation double esterase cytochemical reaction using a single coupling reagent.
    Ainoon O; Jabamoney AJ; Cheong SK
    Malays J Pathol; 1991 Jun; 13(1):47-9. PubMed ID: 1724544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphology and cytochemistry of acute lymphoblastic leukaemia.
    Löffler H; Gassmann W
    Baillieres Clin Haematol; 1994 Jun; 7(2):263-72. PubMed ID: 7803901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnosis of acute leukemia with undifferentiated or minimally differentiated blasts.
    van't Veer MB
    Ann Hematol; 1992 Apr; 64(4):161-5. PubMed ID: 1581403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of beta-catenin discriminates acute myeloid leukaemia from acute lymphoblastic leukaemia.
    Serinsöz E; Neusch M; Büsche G; Wasielewski R; Kreipe H; Bock O
    Br J Haematol; 2004 Aug; 126(3):313-9. PubMed ID: 15257703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the CD33-related Siglec receptor, Siglec-5 (CD170), as a useful marker in both normal myelopoiesis and acute myeloid leukaemias.
    Virgo P; Denning-Kendall PA; Erickson-Miller CL; Singha S; Evely R; Hows JM; Freeman SD
    Br J Haematol; 2003 Nov; 123(3):420-30. PubMed ID: 14617000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esterase reactions in acute myelomonocytic leukemia.
    Kass L
    Am J Clin Pathol; 1977 May; 67(5):485-8. PubMed ID: 67804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of an anti-myeloperoxidase antibody in the diagnosis and classification of acute leukaemia: a comparison with light and electron microscopy cytochemistry.
    Buccheri V; Shetty V; Yoshida N; Morilla R; Matutes E; Catovsky D
    Br J Haematol; 1992 Jan; 80(1):62-8. PubMed ID: 1311196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular markers in acute myeloid leukemia diagnosis.
    Koníková E; Glasová M; Kusenda J; Babusíková O
    Neoplasma; 1998; 45(5):282-91. PubMed ID: 9921916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimally differentiated acute myelogenous leukemia (AML-M0) granulocytic sarcoma presenting in the oral cavity.
    Amin KS; Ehsan A; McGuff HS; Albright SC
    Oral Oncol; 2002 Jul; 38(5):516-9. PubMed ID: 12110349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic clonality analysis: typical patterns in myelodysplastic syndrome and acute myeloid leukaemia.
    van Lom K; Hagemeijer A; Vandekerckhove F; Smit EM; Löwenberg B
    Br J Haematol; 1996 Jun; 93(3):594-600. PubMed ID: 8652379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The classification of acute leukaemia.
    Catovsky D; Matutes E
    Leukemia; 1992; 6 Suppl 2():1-6. PubMed ID: 1578905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.